HE4 is superior to CA125 in the detection of recurrent disease in the follow-up of high risk endometrial cancer patients

Autor:	Karin Abbink, Johanna M.A. Pijnenborg, Fred C.G.J. Sweep, Petra L.M. Zusterzeel, Teun van Herwaarden, Leon F.A.G. Massuger, Anneke Geurts-Moespot
Rok vydání:	2019
Předmět:	Oncology medicine.medical_specialty Reproductive Medicine business.industry Internal medicine Endometrial cancer medicine Recurrent disease Obstetrics and Gynecology business medicine.disease
Zdroj:	European Journal of Obstetrics & Gynecology and Reproductive Biology. 234:e117
ISSN:	0301-2115
DOI:	10.1016/j.ejogrb.2018.08.415
Databáze:	OpenAIRE
Externí odkaz:	https://explore.openaire.eu/search/publication?articleId=doi_________::684ce3141b846d4d225f5c68836dbad6 https://doi.org/10.1016/j.ejogrb.2018.08.415 Zobrazit plný text záznamu Full Text from ScienceDirect